After an incredible week that saw shares of Peregrine Pharmaceuticals (NASDAQ: PPHM) appreciate a surprising 80% on Monday, shares of this biotech took a 10% haircut today. Why the drop? In this video, health care analyst Max Macaluso discusses today's decline and offers his opinion of what investors should watch in the coming weeks.
After a great run this week, it looks like Peregrine is taking a breather.
About the Author
Max is the Technology, Biopharma & Health Care Bureau Chief at Fool.com. Prior to joining the Fool, he completed a PhD in chemistry at the University of Cambridge and an MBA at the College des Ingenieurs.
Follow @TMFMassimo